Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(11%)
Results Posted
17%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
6
67%
Ph phase_2
1
11%
Ph phase_4
1
11%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (11.1%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A6 (66.7%)

Trials by Status

recruiting111%
completed667%
terminated111%
unknown111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingnot_applicable

Predicting The Right Advice at The Right Time in Patients With Hip and Knee OsteoArthritis: the e-cOAch Cross-over.

NCT07423858
unknownphase_2

Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial

NCT04274608
completednot_applicable

Exercise Capacity and Dyspnea in Obese Patients With Metabolic Syndrome: Effects of Weight Loss

NCT03035149
completednot_applicable

The Effect of a Multi-component Weight Management Program on Appetite, Food Preference and Body Weight

NCT02012426
terminatedphase_3

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

NCT01601704
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07423858Not Applicable

Predicting The Right Advice at The Right Time in Patients With Hip and Knee OsteoArthritis: the e-cOAch Cross-over.

Recruiting
NCT04274608Phase 2

Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial

Unknown
NCT03035149Not Applicable

Exercise Capacity and Dyspnea in Obese Patients With Metabolic Syndrome: Effects of Weight Loss

Completed
NCT02012426Not Applicable

The Effect of a Multi-component Weight Management Program on Appetite, Food Preference and Body Weight

Completed
NCT01601704Phase 3

Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)

Terminated
NCT01053130Not Applicable

Weight Loss Interventions in Obese Patients With Stages 3-4 Chronic Kidney Disease: a Randomised Controlled Trial

Completed
NCT00409422Not Applicable

Effects of a Comprehensive Weight Management Program on Obese Adolescents and Children

Completed
NCT00169702Not Applicable

The Effect of a Weight Management Program During Treatment With Olanzapine

Completed
NCT00485823Phase 4

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

Completed

All 9 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9